Board of Directors |
Legal Information |
Alexander Muacevic completed his medical training in neurosurgery at Ludwig Maximilians University, in Munich, Germany. Following this, he completed several internships with neurosurgeons and radiation oncologists in the United States, England and Italy. He became a board certified neurosurgeon in 2003 and a board certified radiosurgeon in 2006. He currently is practicing at the European CyberKnife® Center in Munich, Germany which is a satellite center of the University of Munich Hospital. He is a University teacher at the University Munich and an author of over 50 peer-reviewed publications, several book chapters, and over 100 scientific abstracts. His research interests are full body radiosurgery and minimally invasive image guided therapies, and he is currently a member of several national and international medical societies. Dr. Muacevic joined the Radiosurgery Society Board of Directors in 2007 and currently serves as Chairman of the Board of Directors.
Richard Donald Bucholz attended Yale College, receiving a bachelor in science Cum Laude in molecular biochemistry and biophysics in 1973. He continued at Yale for his medical education and completed a general surgical internship and neurosurgical residency at Yale New Haven Medical Center. He was an Instructor at Yale in 1982-83 before accepting a position of assistant professor at Saint Louis University School of Medicine under Dr. Kenneth R. Smith, Jr. He was certified by the American Board of Neurological Surgery in 1985, and became a full professor in 1996. In 2005, he was named Director of the Division of Neurosurgery and continues his entrepreneurial interest in medical technology. Dr. Bucholz holds a total of 22 patents and others are pending. He is a Fellow of the American College of Surgeons and is a member of numerous medical societies, and has been involved with the Radiosurgery Society for many years and currently serves as Secretary.
Martin Fuss, MD is Professor, Vice Chair, and Director of the Program in Image-Guided Radiation Therapy (IGRT) in the Department of Radiation Medicine at Oregon Health & Science University, since August 2006. Previously, Dr. Fuss was Associate Professor in the Department of Radiation Oncology at The University of Texas Health Science Center at San Antonio. He has expertise in treatment of various diseases including brain, GI tract and lung. Dr. Fuss is an expert in the clinical adaptation of new technological and conceptual developments in radiation oncology, notably intensity-modulated radiotherapy (IMRT), image-guided radiotherapy (IGRT), and stereotactic body radiation therapy (SBRT). Dr. Fuss joined the Board in 2012 and currently serves as Treasurer.
John Kresl completed advanced medical educational and research training in the field of oncology as a National Institute of Health (N.I.H.) supported combined MD/PhD Fellow in Graduate Medical Science training in Molecular and Immunological Tumor Cell Biology, culminating in a Doctor of Philosophy Degree from Northwestern University Graduate School, Evanston, Illinois. In addition to basic science training, Dr. Kresl completed his clinical medical training, receiving a Medical Doctorate Degree from Northwestern University Medical School in Chicago, Illinois. In addition to remaining active in Oncology research, Dr. Kresl is very involved in clinical practice in radiation oncology for all tumor sites. Dr. Kresl has been the principal investigator and co-investigator on dozens of clinical protocols and has published over 150 abstracts, manuscripts and book chapters related to radiation oncology, including editing the first two textbooks on Robotic Radiosurgery. He frequently is an invited lecturer on these topics around the world. Dr. Kresl is Board Certified by the American Board of Radiology in Radiation Oncology. He joined the Board of Directors of the Radiosurgery Society in 2007.
Dr. Fuller earned his doctorate at the University of Washington School of Medicine in Seattle, Washington. He completed his internship at Santa Barbara Cottage Hospital in Santa Barbara, California and his Radiation Oncology residency at LDS Hospital in Salt Lake City, Utah. He is certified by the American Board of Radiology in Radiation Oncology. Dr. Fuller joined Radiation Medical Group in 1988. His interests in the specialty include prostate cancer radiotherapy, prostate brachytherapy, and radiation dose escalation for a variety of malignancies through the appropriate application of intensity modulated radiotherapy (IMRT), brachytherapy and SRS/SBRT techniques. He is one of the directors of Western Cancer Center and Radiation Medical Group, specializing in advanced technology integration. Author of countless research publications, he has treated over 300 patients using the CyberKnife. Dr. Fuller joined the Radiosurgery Society Board of Directors in March 2010.
Paul M. Goldfarb, MD FACS is a surgical oncologist who trained at Memorial Sloan Kettering in New York and the Royal Marsden Hospital in London. He had been in practice in San Diego for 25 years where he is a clinical professor at UCSD and has been president of the California Division of the American Cancer Society. He has been involved with Stereotactic Radiosurgery for 6 years and has worked to develop reimbursement codes for surgeons.
Clinton Medbery was born in Texas but grew up in Charleston, SC. After attending public schools, he graduated from the University of South Carolina in 1971 with a major in biology and minors in chemistry and English. Following a 14 month enlisted stint as a radioman in the Navy, he entered the Medical University of South Carolina, earning his M.D. in 1976. He performed his internal medicine internship at the Naval Regional Medical Center, San Diego, followed by internal medicine residency at Portsmouth Naval Hospital, medical oncology fellowship at a combined Navy/National Cancer Institute program, and then radiation oncology residency at the National Cancer Institute. He is board certified in internal medicine, medical oncology, and radiation oncology. Although interested in all facets of radiation treatment of cancer, his major current interests include CyberKnife radiosurgery, breast brachytherapy, and high dose rate brachytherapy for prostate cancer and other conditions.